15 results for author:"Rondeau J.-M." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors. Rueeger H., Rondeau J.M., McCarthy C., Mobitz H., Tintelnot-Blomley M., Neumann U., Desrayaud S. Bioorg. Med. Chem. Lett. 21:1942-1947(2011) · Mapped (1) |
| Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery. Jahnke W., Rondeau J.M., Cotesta S., Marzinzik A., Pelle X., Geiser M., Strauss A., Gotte M., Bitsch F., Hemmig R. et al. Nat. Chem. Biol. 6:660-666(2010) · Mapped (1) |
| Structure-based design and synthesis of novel P2/P3 modified, non-peptidic beta-secretase (BACE-1) inhibitors. Hanessian S., Shao Z., Betschart C., Rondeau J.M., Neumann U., Tintelnot-Blomley M. Bioorg. Med. Chem. Lett. 20:1924-1927(2010) · Mapped (1) |
| Macrocyclic BACE-1 inhibitors acutely reduce Abeta in brain after po application. Lerchner A., Machauer R., Betschart C., Veenstra S., Rueeger H., McCarthy C., Tintelnot-Blomley M., Jaton A.L., Rabe S., Desrayaud S. et al. Bioorg. Med. Chem. Lett. 20:603-607(2010) · Mapped (1) |
| Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo. Machauer R., Laumen K., Veenstra S., Rondeau J.M., Tintelnot-Blomley M., Betschart C., Jaton A.L., Desrayaud S., Staufenbiel M., Rabe S. et al. Bioorg. Med. Chem. Lett. 19:1366-1370(2009) · Mapped (1) |
| Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors. Machauer R., Veenstra S., Rondeau J.M., Tintelnot-Blomley M., Betschart C., Neumann U., Paganetti P. Bioorg. Med. Chem. Lett. 19:1361-1365(2009) · Mapped (1) |
| Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs. Rondeau J.-M., Bitsch F., Bourgier E., Geiser M., Hemmig R., Kroemer M., Lehmann S., Ramage P., Rieffel S., Strauss A. et al. ChemMedChem 1:267-273(2006) · UniProtKB (1) |
| Structure-based design and synthesis of macroheterocyclic peptidomimetic inhibitors of the aspartic protease beta-site amyloid precursor protein cleaving enzyme (BACE). Hanessian S., Yang G., Rondeau J.M., Neumann U., Betschart C., Tintelnot-Blomley M. J. Med. Chem. 49:4544-4567(2006) · Mapped (1) |
| Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics. Hanessian S., Yun H., Hou Y., Yang G., Bayrakdarian M., Therrien E., Moitessier N., Roggo S., Veenstra S., Tintelnot-Blomley M. et al. J. Med. Chem. 48:5175-5190(2005) · Mapped (1) |
| Structure-based design and protein X-ray analysis of a protein kinase inhibitor. Furet P., Meyer T., Strauss A., Raccuglia S., Rondeau J.M. Bioorg. Med. Chem. Lett. 12:221-224(2002) · Mapped (1) |
| Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1). Ettmayer P., France D., Gounarides J., Jarosinski M., Martin M.-S., Rondeau J.-M., Sabio M., Topiol S., Weidmann B., Zurini M. et al. J. Med. Chem. 42:971-980(1999) · UniProtKB (1) |
| The contribution of lysine-36 to catalysis by human myo-inositol monophosphatase. Ganzhorn A.J., Lepage P., Pelton P.D., Strasser F., Vincendon P., Rondeau J.-M. Biochemistry 35:10957-10966(1996) · UniProtKB (1) |
| Crystal structure of Aeromonas proteolytica aminopeptidase: a prototypical member of the co-catalytic zinc enzyme family. Chevrier B., Schalk C., D'Orchymont H., Rondeau J.-M., Moras D., Tarnus C. Structure 2:283-290(1994) · UniProtKB (1) |
| Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline. Schreuder H.A., Rondeau J.-M., Tardif C., Soffientini A., Sarubbi E., Akeson A., Bowlin T.L., Yanofsky S., Barrett R.W. Eur. J. Biochem. 227:838-847(1995) · UniProtKB (1) |
| Novel NADPH-binding domain revealed by the crystal structure of aldose reductase. Rondeau J.-M., Tete-Favier F., Podjarny A., Reymann J.-M., Barth P., Biellmann J.-F., Moras D. Nature 355:469-472(1992) · UniProtKB (1) |